COGNITIVE IMPAIRMENT IN HUMAN CHRONIC CHAGAS-DISEASE

被引:18
|
作者
MANGONE, CA
SICA, REP
PEREYRA, S
GENOVESE, O
SEGURA, E
RIARTE, A
SANZ, OP
SEGURA, M
机构
[1] HOSP RAMOS MEIJA,DIV NEUROL,BUENOS AIRES,DF,ARGENTINA
[2] ENFERMEDAD CHAGAS DR FATALA CHABEN,INST DIAGNOST & TRATAMIENTO,BUENOS AIRES,ARGENTINA
关键词
CHAGAS DISEASE; COGNITIVE DYSFUNCTION; CEREBRAL WHITE MATTER INVOLVEMENT;
D O I
10.1590/S0004-282X1994000200008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We proposed to investigate subclinical cognitive impairment secondary to chronic Chagas' disease (CCD). No similar study was previously done. The neuropsychological performance of 45 chronic Chagasic patients and 26 matched controls (age, education place and years of residency in endemic area) was compared using the Mini Mental State Exam (MMSE), Weschler Memory Scale (WMS) and the Weschler Adult Intelligent Scale (WAIS). Non-parametric tests and Chi2 were used to compare group means and multivariate statistics in two way frequency tables for measures of independence and association of categorical variables with the disease. Results: Chagasic patients showed lower MMSE scores (p<.004), poor orientation (p<.004), and attention (p<.007). Lower WMS MQ were associated with CCD (Chi2 5.9; p<.01; Fisher test p<.02). Lower WAIS IQ were associated with CCD (Chi2 6.3, p<.01; Fisher test p<.01) being the digit symbol (p<.03), picture completion (p<.03), picture arrangement (p<.01) and object assembly (p<.03) subtests the most affected. The impairment in non-verbal reasoning, speed of information processing, problem solving, learning and sequencing observed in chronic Chagas disease patients resembles the cognitive dysfunction associated with white matter disease.
引用
收藏
页码:200 / 203
页数:4
相关论文
共 50 条
  • [31] ANTIMYOCARDIAL LYMPHOTOXICITY IN CHRONIC EXPERIMENTAL CHAGAS-DISEASE
    CHAMBO, J
    MECKERT, PC
    LAGUENS, RP
    MEDICINA-BUENOS AIRES, 1985, 45 (04) : 394 - 394
  • [32] THE COMPLEMENT-SYSTEM IN CHRONIC CHAGAS-DISEASE
    RIERA, NE
    MALBRAN, A
    RITACCO, V
    COSSIO, PM
    ARANA, RM
    DEBRACCO, MMDE
    MEDICINA-BUENOS AIRES, 1980, 40 (02) : 125 - 132
  • [33] SURVIVAL RATE OF PATIENTS WITH CHRONIC CHAGAS-DISEASE
    CAEIRO, T
    PALMERO, HA
    BAS, J
    IOSA, D
    MEDICINA-BUENOS AIRES, 1982, 42 : 15 - 21
  • [34] IMMUNOLOGICAL PROFILE IN PATIENTS WITH CHRONIC CHAGAS-DISEASE
    BOTTASSO, OA
    MANGIATERRA, L
    LUNA, MB
    AMERIO, N
    MORINI, JC
    MEDICINA-BUENOS AIRES, 1982, 42 (02) : 136 - 140
  • [35] TREATMENT OF ACUTE AND CHRONIC CHAGAS-DISEASE WITH BENZNIDAZOLE
    FERNEX, M
    SURBEK, B
    TROPENMEDIZIN UND PARASITOLOGIE, 1977, 28 (02): : 272 - 273
  • [36] CHAGAS,C AND CHAGAS-DISEASE
    KEAN, BH
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1977, 26 (05): : 1084 - 1087
  • [37] CHAGAS-DISEASE
    CESARDECASTROBARRETO, J
    BRITISH JOURNAL OF ANAESTHESIA, 1979, 51 (12) : 1189 - 1189
  • [38] CHAGAS-DISEASE
    ABRAMOVITSACKERMAN, W
    SAYEGHCARRENO, R
    ISTURIZ, R
    BALDO, AG
    ACQUATELLA, H
    TORRES, J
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1986, 25 (05) : 320 - 321
  • [39] A MOUSE MODEL FOR CHRONIC CHAGAS-DISEASE IN MAN
    COVER, B
    GUTTERIDGE, WE
    MACKIE, MER
    SKILBECK, NQ
    PARASITOLOGY, 1982, 85 (OCT) : R42 - R42
  • [40] ANTIPARASITE EFFECT OF ALLOPURINOL IN CHRONIC CHAGAS-DISEASE
    GALLERANO, R
    SOSA, R
    MEIROVICH, C
    MONTRULL, I
    MEDICINA-BUENOS AIRES, 1985, 45 (06) : 697 - 698